Skip to main content

ADVERTISEMENT

Bruce Theirs, MD, FAAD

Board Review
09/21/2015
1. The absence of co-existent urticaria suggests which diagnosis? a) Angiotensin-converting enzyme inhibitor-associated angioedema b) Allergic (IgE-mediated angioedema) c) Aspirin or non-steroidal anti-inflammatory...
1. The absence of co-existent urticaria suggests which diagnosis? a) Angiotensin-converting enzyme inhibitor-associated angioedema b) Allergic (IgE-mediated angioedema) c) Aspirin or non-steroidal anti-inflammatory...
1. The absence of co-existent...
09/21/2015
The Dermatologist
Board Review
08/25/2015
1. Biopsy shows a metastatic adenocarcinoma. The most common identifiable site of origin is the:
1. Biopsy shows a metastatic adenocarcinoma. The most common identifiable site of origin is the:
1. Biopsy shows a...
08/25/2015
The Dermatologist
Board Review
07/16/2015
1. Which is a systemic opioid receptor antagonist that has been used in the treatment of this symptom? 
1. Which is a systemic opioid receptor antagonist that has been used in the treatment of this symptom? 
1. Which is a systemic opioid...
07/16/2015
The Dermatologist
Board Review
06/16/2015
The contents of these questions are taken from the Galderma Pre-Board Webinar.
The contents of these questions are taken from the Galderma Pre-Board Webinar.
The contents of these questions...
06/16/2015
The Dermatologist
Board Review
05/19/2015
1. Which form of epidermolysis bullosa is most frequently associated with this complication? a) Junctional epidermolysis bullosa—Herlitz type b) Recessive dystrophic epidermolysis bullosa c) Dominant dystrophic...
1. Which form of epidermolysis bullosa is most frequently associated with this complication? a) Junctional epidermolysis bullosa—Herlitz type b) Recessive dystrophic epidermolysis bullosa c) Dominant dystrophic...
1. Which form of epidermolysis...
05/19/2015
The Dermatologist
Board Review
04/14/2016
The contents of these questions are taken from the Galderma Pre-Board Webinar.
The contents of these questions are taken from the Galderma Pre-Board Webinar.
The contents of these questions...
04/14/2016
The Dermatologist
Board Review
04/17/2015
1. These lesions may result from treatment with: a) Vinblastine b) Interleukin-2 c) Colony-stimulating factors d) Niacin e) Acitretin
1. These lesions may result from treatment with: a) Vinblastine b) Interleukin-2 c) Colony-stimulating factors d) Niacin e) Acitretin
1. These lesions may result from...
04/17/2015
The Dermatologist
Board Review
02/17/2016
The deficient nutrient is a cofactor for which enzyme?
The deficient nutrient is a cofactor for which enzyme?
The deficient nutrient is a...
02/17/2016
The Dermatologist
Board Review
03/17/2015
1. Which statement concerning this condition is true? a) Unscheduled DNA synthesis is markedly reduced in the variant group b) Palmer pits are a cutaneous marker for the disease c) It is caused by a defect in the type...
1. Which statement concerning this condition is true? a) Unscheduled DNA synthesis is markedly reduced in the variant group b) Palmer pits are a cutaneous marker for the disease c) It is caused by a defect in the type...
1. Which statement concerning...
03/17/2015
The Dermatologist
Board Review
01/27/2016
These benign hair follicle tumors are part of an inherited syndrome associated with chromophobe and oncocytic types of renal tumors. Additional important pathology is likely to be found in the:
These benign hair follicle tumors are part of an inherited syndrome associated with chromophobe and oncocytic types of renal tumors. Additional important pathology is likely to be found in the:
These benign hair follicle...
01/27/2016
The Dermatologist